TipRanks
HemoGenyx Pharmaceuticals Plc (DE:5HU0)
FRANKFURT:5HU0
Germany Market
5HU0
HemoGenyx Pharmaceuticals Plc
RESEARCH TOOLSreports

HemoGenyx Pharmaceuticals Plc (5HU0) Income Statement

0 Followers

HemoGenyx Pharmaceuticals Plc Income Statement

Last quarter (Q2 2026), HemoGenyx Pharmaceuticals Plc's total revenue was £0.00, a decrease of ― from the same quarter last year. In Q2, HemoGenyx Pharmaceuticals Plc's net income was £-6.55M. See HemoGenyx Pharmaceuticals Plc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
£ 0.00£ 0.00£ 0.00£ 0.00£ 0.00
Gross Profit
£ -588.75K£ -639.28K£ -645.68K£ -2.60M£ -283.65K
Operating Expenses
£ 4.07M£ 5.09M£ 4.91M£ 2.93M£ 2.70M
Depreciation and Amortization
£ 588.75K£ 639.28K£ 645.68K£ 564.07K£ 126.34K
EBITDA
£ -4.07M£ -4.71M£ -5.73M£ -3.42M£ -2.39M
Operating Income
£ -4.66M£ -5.73M£ -5.56M£ 4.00M£ -2.70M
Other Income/Expenses
£ -5.11M£ 101.22K£ -1.14M£ 1.54M£ -2.41M
Pretax Income
£ -9.77M£ -5.63M£ -6.70M£ -3.99M£ -5.11M
Net Income
£ -9.76M£ -5.62M£ -6.69M£ -3.98M£ -5.10M
Per Share Metrics
Basic EPS
£ -2.20£ -1.70£ -2.37£ -1.62£ -2.64
Diluted EPS
£ -2.20£ -1.70£ -2.37£ -1.62£ -2.64
Weighted Average Shares Outstanding
 4.44M 3.30M 2.82M 2.45M 1.93M
Weighted Average Shares Outstanding (Diluted)
 4.44M 3.30M 2.82M 2.45M 1.93M
Currency in GBP

HemoGenyx Pharmaceuticals Plc Earnings and Revenue History